Oxygen Therapy Equipment Market Size, Strategies & Key Players Review by Forecast to 2032

 

Market scenario-

Market Research Future (MRFR's) latest report on the global oxygen therapy equipment market size projected to grow at a CAGR of 5.8% over the forecast period of 2023-2032. Oxygen therapy, also known as O2 therapy, is administered to patients suffering from various respiratory disorders, which provides extra oxygen to keep the patient stable. A range of oxygen therapy equipment are available in the market and are used as per individual patient's requirement. A constant rise in the occurrence rate of life-threatening respiratory devices has propelled the demand for oxygen therapy equipment.

Oxygen therapy equipment have become more efficient and robust in recent years, backed by technological advancements. Besides, improving reimbursement schemes are have also increased the adoption of these devices. Medical device manufacturers are increasingly outlaying massive amounts on R&D activities, which can further the growth of the market over the forecast period. New and innovative products are continually being developed and brought to the marketplace by the key market players. Moreover, these devices have become easily accessible, which is also signaling growth within the market. Furthermore, the market is anticipated to benefit from the consolidating trend of home healthcare, where these devices are extensively used. However, the high developmental cost of these devices and strict regulatory environment governing the medical device industry pose a threat to the market growth. Additionally, frequent alteration in regulations also hinders the growth of the market.

Competitive Landscape

Messer Medical Austria GmbH, Esex Industries, Inc., Linde Healthcare (A Division of Linde Group), Allied Healthcare Products Inc., Fisher & Paykel Healthcare Corporation Limited, Medicop D.O.O, Taiyo Nippon Sanso Corporation, Teleflex Incorporated, Invacare Corporation, Becton Dickinson and Company, Smiths Medical (A Division of Smiths Group PLC), Drägerwerk AG & Co. KGaA, and Philips Healthcare (A Division of Koninklijke Philips N.V.) are the key players in the oxygen therapy equipment market.

Segmentation

The oxygen therapy equipment market has been segmented based on product, portability, application, and end-users.

By product, the oxygen therapy equipment market has been segmented into oxygen source equipment, oxygen delivery devices. The oxygen source equipment segment has been further segmented into oxygen concentrators, liquid oxygen devices, and oxygen cylinders. The oxygen concentrators sub-segment has been further segmented into portable oxygen concentrators and fixed oxygen concentrators. The oxygen delivery devices segment has been further segmented into bag valve masks, venturi masks, oxygen masks, non-rebreather masks, nasal cannulas, and other devices.

By portability, the oxygen therapy equipment market has been segmented into stationary oxygen therapy devices and portable oxygen therapy devices.

By application, the oxygen therapy equipment market has been segmented into cystic fibrosis, asthma, COPD, pneumonia, respiratory distress syndrome, and other diseases.

By end-user, the oxygen therapy equipment market has been segmented into home care settings, hospitals, ambulatory surgical centers & physician offices, and others.

Regional Analysis

Region-wise, the oxygen therapy equipment market has been segmented into the Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

The Americas is at the forefront of the global oxygen therapy equipment market. The presence of a massive patient population suffering from diseases such as COPD, pneumonia, and other respiratory disorders induce high demand for oxygen therapy equipment in the region. High healthcare expenditure in the developed economies of the region combined with favorable reimbursement policies is spurring the growth of the market. The US and Canada are the key contributors to the Americas market.

Europe is following the Americas' lead. Factors such as high government support and increasing incidence rate of respiratory devices are boosting the growth of the market.

The APAC oxygen therapy equipment market is likely to be driven by factors such as the surging prevalence of respiratory disorders, rising government support, high healthcare expenditure in the emerging economies, increased adoption rate, and improving reimbursement landscape.

The MEA market accounts for the least share of the global oxygen therapy equipment market. The majority of the market share is held by the Middle East, where a developed sector and high healthcare expenditure by the GCC countries is boosting the market growth. Concurrently, low healthcare penetration, and poor economic condition hinder the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Infectious Disease Diagnosis & Treatment Market Size, Trends, Growth, and Forecast by 2032

 

Market Highlights
Infectious diseases includes diseases like tuberculosis, hepatitis and many other diseases caused by viruses, fungi or bacteria. Asia Pacific region has tropical climate and more humidity which is more suitable for the growth of the different microorganisms which can cause different diseases. Increasing prevalence of Infectious diseases such as tuberculosis and AIDS in Asia Pacific region is the major driving factor for the growth of the market. Increasing burden of different infectious diseases has increase the demand for the different diagnostic test and treatment for the different infectious diseases. Infectious Disease Treatment Market Share in APAC Size is expected to grow at a CAGR of 2.9% during forecasted period.

Key Players:

The major key player for the Asia Pacific infectious disease diagnosis & treatment market are 

         ·         Abbott Laboratories (US),

         ·         Becton Dickinson & Co. (US),

         ·         Alere, Inc. (US),

         ·         Bio-Rad Laboratories (US),

         ·         Cipla (India), 

         ·         Danaher Corporation (US),

         ·         Glaxosmithkline (UK),

         ·         IPCA Laboratories (India),

         ·         Pfizer (US),

         ·         Roche Diagnostics (Switzerland),

         ·         Johnson And Johnson (US),

         ·         Novartis International (Switzerland),

         ·         Siemens Healthcare (Germany),

         ·         Thermo Fisher Scientific, Inc. (US),

         ·         Vertex Pharmaceuticals (US) and others

Segmentation:
Asia Pacific infectious disease diagnosis & treatment market is segmented

·        on the basis of application into AIDS, Tuberculosis (TB), Hepatitis, HPV, and others.

·        On the basis treatment it is segmented into Antibiotics, antivirals, antifungals, anti-parasitic, alternative medicine and others.

·        On the basis of diagnostic techniques they are immunoassays, PCR, cell cultures and other 

·        By end user the market is segmented as hospitals, clinics, reference labs and others

Due to increasing prevalence infectious diseases like tuberculosis and AIDS in Asia Pacific region has attracted many companies for the development of the market in Asia Pacific region. Companies are concentrating on the development of new and better diagnostic test and treatment for the different diseases. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Regional Analysis

On regional basis, China commands the largest market for Asia Pacific infectious disease diagnosis & treatment market. Presence of huge population and increasing peoples suffering from TB are the major reason for the development of this market in China. China contribute 10 % of total TB population in the world. India has the second largest market for infectious disease diagnosis & treatment. Presence of highest TB patient in the world is the major driving factor for the market. Continuous development in the healthcare sector and increasing healthcare expenditure is also increased the infectious disease diagnosis & treatment market in India.

Related reports-

Global DPT vaccine Market Research Report- Forecast To 2030

Medical Writing Market Research Report - Forecast till 2030

Dental Consumables Market Research Report- North America Forecast till 2030

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Bioadhesive Market Size is projected to set a notable growth

 

Global Bioadhesive Market: Overview

The Global Bioadhesive Market size is expected is expected to grow USD 9.26 billion with a CAGR of 6.80% during the forecast period 2023-2030. According to a recent study report published by the Market Research Future, the global bio adhesive market is expected to gain eminence over the forecast period. The market is forecast to demonstrate a solid growth by 2030 with a remarkable CAGR during the expected period from 2022 – 2030.

Over the last decade, bioadhesives have been considered a potential drug delivery system for oral administration that includes nasal spray, ear drops, eye drops, and ointment hydrogel among others. Bio adhesives are polymers that act as adhesives that contain protein and carbohydrates as major constituents. They are either natural or synthetic polymers. Naturals bio adhesive involve the use of microorganisms like bacteria, fungi, algae, etc. Synthetic polymers are made from biological monomers like sugars. Bio adhesives have number of advantages encouraging their use in healthcare involves their extensive application in drug delivery and tissue repair. They are primarily employed in end user industries such as healthcare, biotechnology, research institutes, packaging industries, etc. The demand of bio adhesives is increasing sue to increase in end users industries.

Global Bioadhesive Market   - Competitive Analysis

The bioadhesive industry has turned into a critical and element power in the global healthcare industry. Through extensive research, it is found out that there has been an extensive utilization in packaging and durability in the market. As there are plenty of large and small market players available. Global Bioadhesive Market Players operating in this market are

Bioadhesive

Alliance Inc.,

Camurus,

Henkel Corporation,

Ashland Inc.,

3M Company,

Adhesives Research,

Yparex B.V.,

EcoSynthetix Inc.,

Adhbio and

others.

Global Bioadhesive Market   - Regional Analysis

Global bio adhesive market is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. Europe is the largest market for bio adhesives in terms of production. Majority of bio adhesive manufacturers in Europe export their products to North America and Asia-Pacific. Increase in research and development activities in bio adhesives favor the growth of this market in Europe. Moreover, biotechnology and research laboratories use bio adhesives on a large scale in this region. America is the second largest market for bio adhesives due to increase in demand of eco-friendly bio adhesive for tissue repair and drug delivery that has favoured the growth of this market in America. Growing emphasis on personal care also increase the demand of bio adhesives in America. Asia-Pacific market is expected to show steady growth in the bio adhesive market during the forecasted period. Japan and India import bio adhesives from European companies which is signifies that there is an increasing demand for bio adhesives for Asia-Pacific for bio adhesive. Middle East and Africa show slow growth in this market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Diabetes Monitors Market Insights Growth During the Forecast Period

 

Diabetes Monitors Market – Overview

The rise in the number of cases for diabetes is surging around the world and has necessitated the growth of diabetes monitors. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The Diabetes Monitors Market Size is projected to rise a CAGR of 7.8 % in the forecast period 2023-2032.

The large patient base diagnosed with diabetes is a key driver for the demand of the diabetes monitors market insight. The nature of diabetes as an ailment requires constant monitoring is expected to contribute to the development of the diabetes monitors market positively. The presence of factors such as growth in technological innovations and rising research funding levels is anticipated to spur the progress of the market in the forecast period.

Competitive Analysis

The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans. The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period.

The Diabetes Monitors Market Players are Abbott Laboratories, Panasonic, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Medtronic, Sanofi, LifeScan, Inc., and others.

Segmental Analysis

The segmentation of the diabetes monitors market is conducted on the basis of component, type, sample, region, and end-users. Based on the sample, the diabetes monitors market is segmented into sweat samples, blood samples, urine samples, and others. By type, the diabetes monitors market is segmented into continuous glucose monitors, point sample test based glucose monitors, and enzyme-free sensor based glucose monitors. The continuous glucose monitors are additionally segmented into re-usable sensor based CGM and disposable sensor based CGM. Based on the components, the diabetes monitors market is segmented into glucose test strips, lancet, and sensors. The sensors are additionally segmented into enzyme-free sensors and enzyme-based sensors. By the end -users, the diabetes monitors market is segmented into hospitals, diagnostic clinics, and home. Based on regions, the market comprises of the Middle East, Europe, Asia Pacific, Africa, and the Americas.

Detailed Regional Analysis     

The regional analysis of the diabetes monitor market includes regions such as the Middle East, Europe, Asia Pacific, Africa, and the Americas. The Americas region is controlling the diabetes monitors market due to the existence of a huge patient population, elevated healthcare expenses, and the existence of the important players. Due to the soaring incidence of the condition, private organization, companies, and government associations are aggressively taking part in improving diabetes care. The European region holds the following position in the diabetes monitors market. It is likely that the support offered by the government bodies for research and development, along with a presence of sophisticated technology is driving the market in the European region.

The Asia Pacific region is projected to be the fastest mounting region through the forecast period. The escalating need for cost-effective glucose monitoring devices, quickly improving technology, and the incidence of a huge patient pool is driving the 000expansion of this market in the Asia Pacific region. The Middle East and African region holds the smallest share in the market due to the incidence of underprivileged and slow rising countries, chiefly, in the African region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Digital 3D Printing Market Share, Size, Trends, Industry Analysis Report to 2030

 

Market Overview

The technology perceives a vast market demand that leads to increasing the size of the market on the global front. According to Market Research Future (MRFR), the global digital 3D printing market share is poised to touch a valuation of USD 14404.36 MN by 2030, registering 21.20% CAGR a throughout the forecast period (2022 – 2030). Rising advances in the digital 3D printing technology led by the rising R&D funding & initiatives of public-private sectors are the major growth drivers contributing to the growth of the market.

Global digital 3D printing market is witnessing a constant rise in its revenues, mainly due to the rising adoption of 3D printing technology across industries. Some of the digital 3d printing market insights include the rapidly evolving 3D printing technology and increasing applications of this technology in the healthcare industry. 3D printing technologies have not only improved practices in the medical field but have also empowered manufacturers of medical devices and researchers, proving their worth in dental & orthodontic treatments, orthopedic implants, tissue engineering, and drug development.

Advantages that technology offers are boosting its application rate in the 3D printing market. Besides, the rising popularity of 3D printing technology among end-users is expected to push the market growth in the upcoming years. On the other hand, factors such as the lack of expertise and knowledge about the technology are acting as major growth impeders for the growth of the digital 3D printing industry. 

Also, the slow adoption of the digital 3D printing technology is inhibiting the market growth extensively, especially in the developing regions such as the APAC and MEA. However, the situation is expected to improve dramatically over the assessment period.

Digital 3D Printing Market   - Competitive Analysis

Highly competitive, the digital 3D printing market outlook appears well-established with the presence of several notable players. Players operating in the market strive to develop new products and thus their portfolio with cost-competitive prices. They make substantial R&D investments for the development of new products & technologies and to strengthen their market presence by expanding the distribution network and regional footprints. This further allows them to form collaborations and strategic initiations such as mergers & acquisitions, and others with other players in the digital 3D printing industry.

Major Players:

Global digital 3D printing market players include

• 3D Systems, Inc. (US),
• Stratasys Ltd (US),
• Carbon, Inc. (US),
• Formlabs (US),
• EnvisionTEC (US),
• ExOne (US),
• General Electric (US),
• Materialise (Europe),
• Micron Dental (US), and
• Renishaw PLC (UK), among others. 

Digital 3D Printing Market   - Segments

The analysis is segmented into six main dynamics to widen the scope of understanding,

By Component           :  System/Device and Software/Services

By Material                 : Polymers, Metal & Alloy, Ceramics, and others.

By Technology            : Stereo Lithography, Deposition Modeling, Laser Sintering Jetting Technology, Electron Beam Melting, and others.

By Applications          : Dental (Clear Aligners, Dental Implants, Endosteal Implants,  Sub-Periosteal Implants, Dentures Crowns & Bridges, others)  Prosthetics (Prosthetics implants, Hip Disarticulation, Lower Limb/Extremity Componentry, Finger Splints, others), Orthopedics,  Medical Components, Tissue Engineering (Bone & Cartilage Scaffolds, Ligament & Tendon Scaffolds, others), Hearing Aids, Drug Screening, and others.

By End User                : Hospitals & Surgical Centers, Dental Clinics & Laboratories (Offices), Pharmaceutical & Biotechnology Companies, and others.

By Regions                  : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World

Global Digital 3D Printing Market   - Regional Analysis

North America dominates the global digital 3D printing market. The largest market share attributes to the presence of established market players in the region and the augmenting demand for the digital 3D printing technology. Besides, medical device companies in the region, alongside the rising prevalence of diseases and increased adoption of medical devices in the treatment foster the growth of the market.

Moreover, digital 3D printing market trends, such as increasing advances and adoption of the technology is expected to drive the market growth further. Furthermore, the well-established 3D printing manufacturing industries in the region are substantiating the growth in the market excellently. In 2018, the US market held the largest share in the North American digital 3D printing market.

Europe stands second in the global digital 3D printing market, heading with the favorable government initiatives for the development of the technology. Rising prevalence of lifestyle diseases and the presence of well-established medical device industries in Germany, the UK, and France influence the regional market growth. The size of the digital 3D printing market in European territory is estimated to increase rapidly during the assessment period.

The digital 3D printing market in the Asia Pacific region is growing briskly attributing to the increasing per capita health spending, geriatric populaces, and incidence of accidents. Besides, the proliferating healthcare sectors in China, Japan, India, and Australia are substantiating the growth of the market.

Furthermore, the rising adoption of medical devices is a dominant driving force pushing the regional market growth forward. Substantial investments to expand 3D printing capabilities in rapidly developing APAC economies such as China, South Korea, Japan, and India are allowing the APAC digital 3D printing market to remain among the top leaders.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Patient Engagement Solutions Market Share accelerating a CAGR during the forecast period

 

Market Overview:

The financing in the healthcare information technology (IT) sector has increased steadily, and this is estimated to motivate the Patient Engagement Solutions Market 2022. The healthcare reports are made by Market Research Future, which includes market options for expansion.

The paramount need to ensuring patient approval is projected to create an optimistic scope for the Patient Engagement Solutions Market Share in the forecast period 2023-2032. The chronic diseases are surging at an alarming rate, and this is estimated to create an accelerated application potential for the patient engagement software solutions market.

Patient Engagement Solutions Market Overview and Report Analysis By Component (Hardware, Software, Service), Delivery Mode (Web-based, Cloud-based, On-Premise), Therapeutic Area (Chronic Disease, Fitness Management), Application (Social Management, Health Management, Financial Health Management) and End-User (Hospitals and healthcare providers, Individual users) - Forecast to 2030

Competitive Analysis

The decrease in supply chain bottlenecks is appraised as a primary objective that challengers in the market are assessed to tackle urgently in the forecast period. The prerequisite for sustainability in the market is projected to be formed by renewing the open cash movements. The market is estimated to open up to new and lucrative opportunities for expansion in the forecast period. The contenders for the majority share are predicted to transform the market backdrop considerably in the forecast period. The government bodies of several countries are likely to play a central role in the revitalization of the global market, post the deceleration seen in the aftermath of the pandemic. The end-users in the market are estimated to show variety in terms of the preference in the coming period. The markets are estimated to conduct more of their business dealings online than in brick-and-mortar stores.

Key Players:

The Patient Engagement Solutions Market Players are

         ·         Athenahealth, Inc. (US),

         ·         Cerner Corporation (US),

         ·         IBM (US),

         ·         Welvu (US),

         ·         Aetna Inc. (US),

         ·         Mckesson Corporation (US),

         ·         Medecision, Inc. (US),

         ·         Lincor Solutions (US),

         ·         Orion Health Ltd. (New Zealand),

         ·         Allscripts Healthcare Solutions, Inc. (US),

         ·         Oneview Ltd (Ireland), and

         ·         Get Real Health (US).

Segmental Analysis

The segmental appraisal of the Patient Engagement Solutions Market has been conducted based on application, delivery mode, component, therapeutic area, region, and end-user.

·        Based on the end-users, the patient engagement software solutions market consists of healthcare payers, individual users, hospitals and healthcare providers, and others.

·        Based on component, the patient engagement software solutions market has been segmented into software, hardware, and service.

·        Based on the therapeutic area, the patient engagement solutions market is segmented into women’s health management, fitness management, chronic disease, and others.

·        The application-based segmentation of the patient engagement solutions market is segmented into health management, home health management, social management, and financial health management.

·        On the basis of delivery mode, the patient engagement solution market has been segmented into cloud-based, web-based, and on-premises.

·        On the basis of regions, the patient engagement software solutions market has been segmented into the Americas, Asia Pacific, Europe, Africa, and the Middle East.

Detailed Regional Analysis

The regional appraisal of the Patient Engagement Solutions Market Outlook includes regions such as the Americas, Asia Pacific, Europe, Africa, and the Middle East. The Americas regional market is the largest patient engagement software solutions market. The application of incentives to move the encumbrance of risk from healthcare payers to suppliers and increasing insurance holders are expected to push the growth of the market. The necessity for patient engagement solutions is elevated in the European region owing to the growing number of healthcare centers in the region and intensifying implementation of novel technologies in the healthcare industry. The Asia Pacific regional market has the world’s largest population and, as a result, a fast-developing healthcare sector. Despite the evolving healthcare infrastructure, patient engagement solutions are exploited at every level of healthcare in numerous medical techniques, which is estimated to be accountable for the intensifying demand for patient engagement solutions in the region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

Drug Device Combination Market Share : A Technology Analysis of the Key Products & Applications

 

Market Analysis

The global drug device combination market share is predicted to grow at a whopping 7.2% CAGR over the assessment period 2023-2032. Drug-device combination products relate a drug with that of a medical device to bridge various regulatory frameworks (device or drug). This can be a single product having several components such as drug-eluting stents, transdermal patches or products that are separately packed yet intended for use exclusively with a definite counterpart. Drug-device combination products offer an array of advantages namely targeted drug delivery, improved patient compliance, controlled drug administration and minimal side effects. Owing to its increased sophistication and different advantages, drug device combination products are widely adopted all across the medical sector.

There are plentiful factors that is boosting the growth of the drug device combination market. These factors as per the Market Research Future (MRFR) report include increasing incidences of urology, prostate cancer, diabetic neuropathy, colorectal cancer, respiratory problems and cardiovascular diseases, growing healthcare expenditure, increasing awareness of market products, growing geriatric population, technological advancements in the drug-device combination product, increase in homebased healthcare market, high market potential, and increase in healthcare expenditure. On the contrary, side effects, existence of low-income countries, soaring price of products, strict government rules for the approval of these devices and errors and post-complications leading to various product recalls are factors that may deter drug device combination market growth.

Key Players

Drug device combination market players profiled in the industry include Zimmer Holding, Inc, Wright Medical Group, Inc., Stryker Corporation, St. Jude Medical Inc, Smith & Nephew Plc, Covidien Ltd, Cook Critical Care, Inc., C.R. BARD, Inc., Boston Scientific Corporation, Biotronik, Biometrix Medical, Biomet Orthopedics, Inc, AlloSource, Abbott Laboratories, 3M, and others.

 

Market Segmentation

MRFR report provides an extensive segmental analysis of the drug device combination market outlook on the basis of product, application and end-users.

Based on product, it is segmented into advanced wound care products, catheter and others. Catheter is again segmented into wound drainage catheter, thermodilution catheters, oximetry catheters, cardiovascular catheters, urological catheters, antimicrobial catheter and others. Advanced wound care products are again segmented into photodynamic therapy, drug eluting stents, antibiotic bone cements, bone graft substitutes and antibiotic wound care. Bone graft substitutes is again segmented into cell-based bone graft substitutes, allograft-based bone graft substitutes, ceramic based bone graft substitute and others.

Based on application, the drug device combination market is segmented into ophthalmic treatment, wound care, antimicrobial applications, bone treatment, peripheral arterial disease, non-cardiovascular treatments, tachycardia management, coronary angioplasty and others.

Based on end-users, it is segmented into academic and research organization, ambulatory centers, hospitals and clinics and others.

Regional Analysis

By region, the drug device combination market insights covers growth opportunities and latest trends across the Americas, Europe, Asia Pacific and Middle East and Africa. Of these, the Americas will sway the market over the assessment period owing to increasing incidence of cardiovascular diseases, presence of key market players, developed healthcare sector in Canada and the US, high healthcare expenditure and suitable reimbursement policies. In the European region, the drug device combination market will have the second major share due to huge patient pool, presence of developed economies, increasing awareness about the device and presence of healthcare infrastructure that is well-developed. In the APAC region, the drug device combination market is expected to grow at the fastest pace owing to growing support from the government for foreign investments, growing healthcare sector and growing penetration of market players here. On the other hand, the drug device combination market in the Middle East and Africa will have minimal share in the market owing to low per capita income and presence of poor economies. The Middle East is anticipated to have a major share in the drug device combination market owing to presence of developed economies such as Dubai, Saudi Arabia, United Arab Emirates and others and increasing funds made by the government in the healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America